Australia · Delayed Price · Currency is AUD XRF Scientific Statistics
Total Valuation
XRF Scientific has a market cap or net worth of AUD 266.68 million. The enterprise value is 258.86 million.
| Market Cap | 266.68M |
| Enterprise Value | 258.86M |
Important Dates
The next estimated earnings date is Monday, November 17, 2025.
| Earnings Date | Nov 17, 2025 |
| Ex-Dividend Date | Sep 11, 2025 |
Share Statistics
XRF Scientific has 142.99 million shares outstanding. The number of shares has increased by 1.72% in one year.
| Current Share Class | 142.99M |
| Shares Outstanding | 142.99M |
| Shares Change (YoY) | +1.72% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 20.32% |
| Owned by Institutions (%) | 2.79% |
| Float | 100.40M |
Valuation Ratios
The trailing PE ratio is 25.20 and the forward PE ratio is 22.47.
| PE Ratio | 25.20 |
| Forward PE | 22.47 |
| PS Ratio | 4.49 |
| PB Ratio | 4.43 |
| P/TBV Ratio | 6.06 |
| P/FCF Ratio | 31.77 |
| P/OCF Ratio | 26.30 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.77, with an EV/FCF ratio of 30.84.
| EV / Earnings | 24.93 |
| EV / Sales | 4.35 |
| EV / EBITDA | 15.77 |
| EV / EBIT | 17.47 |
| EV / FCF | 30.84 |
Financial Position
The company has a current ratio of 4.40, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.40 |
| Quick Ratio | 2.36 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.53 |
| Interest Coverage | 57.65 |
Financial Efficiency
Return on equity (ROE) is 17.87% and return on invested capital (ROIC) is 14.84%.
| Return on Equity (ROE) | 17.87% |
| Return on Assets (ROA) | 13.13% |
| Return on Invested Capital (ROIC) | 14.84% |
| Return on Capital Employed (ROCE) | 23.42% |
| Revenue Per Employee | 1.24M |
| Profits Per Employee | 216,322 |
| Employee Count | 48 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.71 |
Taxes
In the past 12 months, XRF Scientific has paid 4.25 million in taxes.
| Income Tax | 4.25M |
| Effective Tax Rate | 29.15% |
Stock Price Statistics
The stock price has increased by +7.18% in the last 52 weeks. The beta is 0.70, so XRF Scientific's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +7.18% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 30.76 |
| Average Volume (20 Days) | 233,961 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XRF Scientific had revenue of AUD 59.45 million and earned 10.38 million in profits. Earnings per share was 0.07.
| Revenue | 59.45M |
| Gross Profit | 28.79M |
| Operating Income | 14.82M |
| Pretax Income | 14.59M |
| Net Income | 10.38M |
| EBITDA | 15.63M |
| EBIT | 14.82M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 12.23 million in cash and 4.41 million in debt, giving a net cash position of 7.82 million or 0.05 per share.
| Cash & Cash Equivalents | 12.23M |
| Total Debt | 4.41M |
| Net Cash | 7.82M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 60.17M |
| Book Value Per Share | 0.43 |
| Working Capital | 32.43M |
Cash Flow
In the last 12 months, operating cash flow was 10.14 million and capital expenditures -1.75 million, giving a free cash flow of 8.39 million.
| Operating Cash Flow | 10.14M |
| Capital Expenditures | -1.75M |
| Free Cash Flow | 8.39M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 48.43%, with operating and profit margins of 24.92% and 17.47%.
| Gross Margin | 48.43% |
| Operating Margin | 24.92% |
| Pretax Margin | 24.54% |
| Profit Margin | 17.47% |
| EBITDA Margin | 26.29% |
| EBIT Margin | 24.92% |
| FCF Margin | 14.12% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.34%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.34% |
| Dividend Growth (YoY) | 15.38% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 43.49% |
| Buyback Yield | -1.72% |
| Shareholder Yield | 0.57% |
| Earnings Yield | 3.89% |
| FCF Yield | 3.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XRF Scientific has an Altman Z-Score of 13.8 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.8 |
| Piotroski F-Score | 5 |